Litcius/Paper detail

Safety profile of risankizumab in the treatment of psoriasis patients with concomitant hepatitis B or C infection: A multicentric retrospective cohort study of 49 patients

Christian Ciolfi, Riccardo Balestri, Federico Bardazzi, Martina Burlando, Karin Chersi, Antonio Costanzo, Paolo Dapavo, Paolo Gisondi, Piergiorgio Malagoli, Miriam Pizzolato, Giulia Rech, Francesco Paolo Russo, Sara Battistella, Stefano Piaserico

2023Journal of the European Academy of Dermatology and Venereology14 citationsDOI

Abstract

Data supporting the findings of this study are available from the corresponding author upon reasonable request.

Topics & Concepts

MedicineConcomitantRetrospective cohort studyPsoriasisCohortCohort studyHepatitis CInternal medicineHepatitis BPediatricsDermatologyHepatitis B Virus StudiesPsoriasis: Treatment and PathogenesisHepatitis C virus research
Safety profile of risankizumab in the treatment of psoriasis patients with concomitant hepatitis B or C infection: A multicentric retrospective cohort study of 49 patients | Litcius